Inspector General: More Oversight Needed of Research Conflict-of-Interest Policies

If research institutions do not voluntarily strengthen their conflict-of-interest policies and procedures, pressure for external regulations is likely to increase, HHS Inspector General Daniel Levinson said as he called on the FDA and NIH to step up their oversight. As part of an ongoing inquiry into conflicts of interest between industry and researchers, the Office of Inspector General is evaluating a number of institutions that received NIH research grants in fiscal 2008, Levinson said in a keynote address at a recent conference of the American Healthcare Lawyers Association.
Clinical Trials Advisor